ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Civica taps Thermo Fisher for drug manufacturing

by Michael McCoy
January 24, 2020 | APPEARED IN VOLUME 98, ISSUE 4

 

Civica Rx, a nonprofit established by health systems and philanthropies to reduce generic drug shortages in the US, has picked the pharma services division of Thermo Fisher Scientific to develop and make drugs under Civica-owned abbreviated new drug applications. The partners say they will focus on nine drugs in short supply or with fragile supply chains. Civica has similar pacts with other manufacturers, including Hikma Pharmaceuticals and Xellia Pharmaceuticals.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment